Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. WMT
2. JMKE
3. ROST
4. AAP
5. NVDA
6. SPY
7. BABA
8. REF
9. TSLA
10. SPCX

Go back to Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers
AGENUS (NASDAQ: AGEN) Delayed: 8.09 --0 (-0%)
Previous Close $8.09    52 Week High $7.49 
Open $8.09    52 Week Low $2.61 
Day High $8.09    P/E N/A 
Day Low $8.09    EPS $-1.10 
Volume 197